Literature DB >> 26150125

Epidemiology research in rheumatology-progress and pitfalls.

Deborah P M Symmons1.   

Abstract

Epidemiology research is a vital component of clinical studies in all medical fields. This Review provides a brief introduction to the methodology and interpretation of population and clinical epidemiology studies of musculoskeletal disorders. Data sources (including 'big data' and the issue of missing data), study design (cross-sectional, case-control and cohort studies, including clinical trial design) and the interpretation of study results are discussed with examples from the field of rheumatology, particularly using findings in patients with rheumatoid arthritis. Two or more treatments can be compared in clinical trials using a variety of study designs including superiority, noninferiority or equivalence. The different types of risk in epidemiological studies-absolute, attributable, background and relative-are important concepts in epidemiological research and their relative usefulness to clinicians and patients should be considered carefully. The potential pitfalls and challenges of generalizing the results of epidemiological studies to understanding disease aetiology and to clinical practice are also emphasized. The aim of the Review is to help readers to critically appraise published articles that use epidemiological designs or methods.

Entities:  

Mesh:

Year:  2015        PMID: 26150125     DOI: 10.1038/nrrheum.2015.92

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  54 in total

Review 1.  Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases.

Authors:  Hilal Maradit Kremers; Cynthia S Crowson; Sherine E Gabriel
Journal:  Rheum Dis Clin North Am       Date:  2004-11       Impact factor: 2.670

2.  Selection of controls in case-control studies. III. Design options.

Authors:  S Wacholder; D T Silverman; J K McLaughlin; J S Mandel
Journal:  Am J Epidemiol       Date:  1992-05-01       Impact factor: 4.897

3.  Quality of reporting of noninferiority and equivalence randomized trials.

Authors:  Anne Le Henanff; Bruno Giraudeau; Gabriel Baron; Philippe Ravaud
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

4.  Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis.

Authors:  Lihi Eder; Tamryn Law; Vinod Chandran; Sutha Shanmugarajah; Hua Shen; Cheryl F Rosen; Richard J Cook; Dafna D Gladman
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-08       Impact factor: 4.794

5.  Estimating the diagnostic accuracy of rheumatoid factor in UK primary care: a study using the Clinical Practice Research Datalink.

Authors:  Anne Miller; Alison L Nightingale; Cormac J Sammon; Kamal R Mahtani; Tim A Holt; Neil J McHugh; Raashid A Luqmani
Journal:  Rheumatology (Oxford)       Date:  2015-06-08       Impact factor: 7.580

6.  Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.

Authors:  C O Bingham; A I Sebba; B R Rubin; G E Ruoff; J Kremer; S Bird; S S Smugar; B J Fitzgerald; K O'Brien; A M Tershakovec
Journal:  Rheumatology (Oxford)       Date:  2006-08-27       Impact factor: 7.580

7.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

8.  Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study.

Authors:  P Stolt; H Källberg; I Lundberg; B Sjögren; L Klareskog; L Alfredsson
Journal:  Ann Rheum Dis       Date:  2004-08-19       Impact factor: 19.103

Review 9.  Osteoarthritis: new insights. Part 1: the disease and its risk factors.

Authors:  D T Felson; R C Lawrence; P A Dieppe; R Hirsch; C G Helmick; J M Jordan; R S Kington; N E Lane; M C Nevitt; Y Zhang; M Sowers; T McAlindon; T D Spector; A R Poole; S Z Yanovski; G Ateshian; L Sharma; J A Buckwalter; K D Brandt; J F Fries
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

10.  A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study.

Authors:  Dae Hyun Yoo; Pawel Hrycaj; Pedro Miranda; Edgar Ramiterre; Mariusz Piotrowski; Sergii Shevchuk; Volodymyr Kovalenko; Nenad Prodanovic; Mauricio Abello-Banfi; Sergio Gutierrez-Ureña; Luis Morales-Olazabal; Michael Tee; Renato Jimenez; Omid Zamani; Sang Joon Lee; HoUng Kim; Won Park; Ulf Müller-Ladner
Journal:  Ann Rheum Dis       Date:  2013-05-16       Impact factor: 19.103

View more
  4 in total

1.  Clinical and Molecular Findings after Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data.

Authors:  Lynette Keyes-Elstein; Ashley Pinckney; Ellen Goldmuntz; Beverly Welch; Jennifer M Franks; Viktor Martyanov; Tammara A Wood; Leslie Crofford; Maureen Mayes; Peter McSweeney; Richard Nash; George Georges; M E Csuka; Robert Simms; Daniel Furst; Dinesh Khanna; E William St Clair; Michael L Whitfield; Keith M Sullivan
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-09-17       Impact factor: 4.794

2.  Influence of IL6R gene polymorphisms in the effectiveness to treatment with tocilizumab in rheumatoid arthritis.

Authors:  M Maldonado-Montoro; M Cañadas-Garre; A González-Utrilla; M Ángel Calleja-Hernández
Journal:  Pharmacogenomics J       Date:  2016-12-13       Impact factor: 3.550

Review 3.  Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability.

Authors:  Etheresia Pretorius; Oore-Ofe Akeredolu; Prashilla Soma; Douglas B Kell
Journal:  Exp Biol Med (Maywood)       Date:  2016-11-26

4.  From Rheumatology 1.0 to Rheumatology 4.0 and beyond: the contributions of Big Data to the field of rheumatology.

Authors:  Nicola Luigi Bragazzi; Giovanni Damiani; Mariano Martini
Journal:  Mediterr J Rheumatol       Date:  2019-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.